CN111789913A - Traditional Chinese medicine compound preparation for treating salpingitis of laying hens and application - Google Patents
Traditional Chinese medicine compound preparation for treating salpingitis of laying hens and application Download PDFInfo
- Publication number
- CN111789913A CN111789913A CN202010800627.0A CN202010800627A CN111789913A CN 111789913 A CN111789913 A CN 111789913A CN 202010800627 A CN202010800627 A CN 202010800627A CN 111789913 A CN111789913 A CN 111789913A
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicine
- traditional chinese
- laying hens
- compound preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 114
- 238000002360 preparation method Methods 0.000 title claims abstract description 51
- 150000001875 compounds Chemical class 0.000 title claims abstract description 44
- 208000007893 Salpingitis Diseases 0.000 title claims abstract description 42
- QMGVPVSNSZLJIA-XBPPHNHDSA-N (4aR,5aS,8aR,15bR)-4a,5,5a,7,8,13a,15,15a,15b,16-decahydro-2H-4,6-methanoindolo[3,2,1-ij]oxepino[2,3,4-de]pyrrolo[2,3-h]quinoline-14-one Chemical compound C1([C@H]2[C@H]3C4)N(C=5C6=CC=CC=5)C(=O)CC2OCC=C3CN2[C@@H]4[C@]16CC2 QMGVPVSNSZLJIA-XBPPHNHDSA-N 0.000 claims abstract description 25
- 240000007801 Strychnos nux vomica Species 0.000 claims abstract description 25
- 229910052602 gypsum Inorganic materials 0.000 claims abstract description 25
- 239000010440 gypsum Substances 0.000 claims abstract description 25
- 240000005801 Carthamus tinctorius Species 0.000 claims abstract description 24
- 235000003255 Carthamus tinctorius Nutrition 0.000 claims abstract description 24
- 235000009242 dandelion Nutrition 0.000 claims abstract description 24
- 235000014079 dandelion Nutrition 0.000 claims abstract description 24
- 241001061264 Astragalus Species 0.000 claims abstract description 22
- 235000000604 Chrysanthemum parthenium Nutrition 0.000 claims abstract description 22
- 235000010696 Leonuro Nutrition 0.000 claims abstract description 22
- 235000006533 astragalus Nutrition 0.000 claims abstract description 22
- 235000010110 Astragalus glycyphyllos Nutrition 0.000 claims abstract description 21
- 239000000463 material Substances 0.000 claims abstract description 10
- 241000266851 Hedysarum polybotrys Species 0.000 claims abstract description 7
- 241000245665 Taraxacum Species 0.000 claims description 23
- 239000008187 granular material Substances 0.000 claims description 23
- 239000000843 powder Substances 0.000 claims description 21
- 241000207925 Leonurus Species 0.000 claims description 20
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 18
- 239000000706 filtrate Substances 0.000 claims description 12
- 239000002994 raw material Substances 0.000 claims description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 8
- 238000001914 filtration Methods 0.000 claims description 6
- 238000002156 mixing Methods 0.000 claims description 6
- 239000002552 dosage form Substances 0.000 claims description 5
- 238000005303 weighing Methods 0.000 claims description 5
- 238000004140 cleaning Methods 0.000 claims description 4
- 238000001035 drying Methods 0.000 claims description 4
- 239000012530 fluid Substances 0.000 claims description 4
- 238000001816 cooling Methods 0.000 claims description 3
- 230000002045 lasting Effects 0.000 claims description 3
- 238000004806 packaging method and process Methods 0.000 claims description 3
- 238000001694 spray drying Methods 0.000 claims description 3
- 230000001954 sterilising Effects 0.000 claims description 3
- 235000013601 eggs Nutrition 0.000 abstract description 43
- 230000000694 effects Effects 0.000 abstract description 37
- 229940079593 drugs Drugs 0.000 abstract description 21
- 210000004369 Blood Anatomy 0.000 abstract description 16
- 239000008280 blood Substances 0.000 abstract description 16
- 238000004519 manufacturing process Methods 0.000 abstract description 13
- 230000036541 health Effects 0.000 abstract description 9
- 230000001737 promoting Effects 0.000 abstract description 9
- 239000000126 substance Substances 0.000 abstract description 9
- 231100000331 toxic Toxicity 0.000 abstract description 9
- 239000000203 mixture Substances 0.000 abstract description 8
- 230000002588 toxic Effects 0.000 abstract description 8
- 206010059866 Drug resistance Diseases 0.000 abstract description 5
- 230000017531 blood circulation Effects 0.000 abstract description 5
- 230000002950 deficient Effects 0.000 abstract description 4
- 231100000765 Toxin Toxicity 0.000 abstract description 3
- 239000003640 drug residue Substances 0.000 abstract description 3
- 239000003053 toxin Substances 0.000 abstract description 3
- 240000007890 Leonurus cardiaca Species 0.000 abstract description 2
- 240000001949 Taraxacum officinale Species 0.000 abstract 1
- 230000001965 increased Effects 0.000 description 15
- 230000002829 reduced Effects 0.000 description 15
- 241000700159 Rattus Species 0.000 description 12
- 210000004185 Liver Anatomy 0.000 description 11
- 210000002966 Serum Anatomy 0.000 description 11
- 201000010099 disease Diseases 0.000 description 11
- 241000287828 Gallus gallus Species 0.000 description 9
- 208000002193 Pain Diseases 0.000 description 9
- 230000017448 oviposition Effects 0.000 description 9
- 230000036407 pain Effects 0.000 description 9
- 230000032696 parturition Effects 0.000 description 9
- 108010002350 Interleukin-2 Proteins 0.000 description 7
- 230000036039 immunity Effects 0.000 description 7
- 230000001976 improved Effects 0.000 description 7
- 230000000144 pharmacologic effect Effects 0.000 description 7
- 230000001105 regulatory Effects 0.000 description 7
- 230000002522 swelling Effects 0.000 description 7
- 108090001005 Interleukin-6 Proteins 0.000 description 6
- 210000000952 Spleen Anatomy 0.000 description 6
- 102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 description 6
- 108010001801 Tumor Necrosis Factor-alpha Proteins 0.000 description 6
- 235000009508 confectionery Nutrition 0.000 description 6
- 206010061218 Inflammation Diseases 0.000 description 5
- 210000003734 Kidney Anatomy 0.000 description 5
- 210000004072 Lung Anatomy 0.000 description 5
- 229930013930 alkaloids Natural products 0.000 description 5
- 230000004054 inflammatory process Effects 0.000 description 5
- 230000001717 pathogenic Effects 0.000 description 5
- 230000001603 reducing Effects 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 229940064005 Antibiotic throat preparations Drugs 0.000 description 4
- 229940083879 Antibiotics FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE Drugs 0.000 description 4
- 229940042052 Antibiotics for systemic use Drugs 0.000 description 4
- 229940042786 Antitubercular Antibiotics Drugs 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 4
- 210000003746 Feathers Anatomy 0.000 description 4
- 229940093922 Gynecological Antibiotics Drugs 0.000 description 4
- 210000002784 Stomach Anatomy 0.000 description 4
- 229940024982 Topical Antifungal Antibiotics Drugs 0.000 description 4
- 150000003797 alkaloid derivatives Chemical class 0.000 description 4
- 239000003242 anti bacterial agent Substances 0.000 description 4
- 230000003110 anti-inflammatory Effects 0.000 description 4
- 230000003115 biocidal Effects 0.000 description 4
- 230000002708 enhancing Effects 0.000 description 4
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N flavone Chemical compound O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 4
- 229930003944 flavones Natural products 0.000 description 4
- 235000011949 flavones Nutrition 0.000 description 4
- 238000009472 formulation Methods 0.000 description 4
- 230000002496 gastric Effects 0.000 description 4
- 229940079866 intestinal antibiotics Drugs 0.000 description 4
- 229940005935 ophthalmologic Antibiotics Drugs 0.000 description 4
- 239000002245 particle Substances 0.000 description 4
- -1 triterpene glycoside Chemical class 0.000 description 4
- 239000000341 volatile oil Substances 0.000 description 4
- 206010000060 Abdominal distension Diseases 0.000 description 3
- 206010001928 Amenorrhoea Diseases 0.000 description 3
- 208000005171 Dysmenorrhea Diseases 0.000 description 3
- 206010013935 Dysmenorrhoea Diseases 0.000 description 3
- 210000003101 Oviducts Anatomy 0.000 description 3
- 208000004880 Polyuria Diseases 0.000 description 3
- 208000008425 Protein Deficiency Diseases 0.000 description 3
- 201000000736 amenorrhea Diseases 0.000 description 3
- 231100000540 amenorrhea Toxicity 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 230000001488 breeding Effects 0.000 description 3
- ZYGHJZDHTFUPRJ-UHFFFAOYSA-N coumarin Natural products C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 description 3
- 230000004069 differentiation Effects 0.000 description 3
- 230000003203 everyday Effects 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 150000002215 flavonoids Chemical class 0.000 description 3
- 229930003935 flavonoids Natural products 0.000 description 3
- 239000000796 flavoring agent Substances 0.000 description 3
- 235000019634 flavors Nutrition 0.000 description 3
- 238000003304 gavage Methods 0.000 description 3
- 150000004676 glycans Polymers 0.000 description 3
- 150000002338 glycosides Chemical class 0.000 description 3
- 235000008216 herbs Nutrition 0.000 description 3
- 230000027939 micturition Effects 0.000 description 3
- 238000005457 optimization Methods 0.000 description 3
- 150000007524 organic acids Chemical class 0.000 description 3
- 229920001282 polysaccharide Polymers 0.000 description 3
- 239000005017 polysaccharide Substances 0.000 description 3
- 150000004804 polysaccharides Polymers 0.000 description 3
- 231100000486 side effect Toxicity 0.000 description 3
- 201000010874 syndrome Diseases 0.000 description 3
- 235000019640 taste Nutrition 0.000 description 3
- LEBRGKZHLICZCZ-UHFFFAOYSA-N 2-(chloromethyl)-4-(4-nitrophenyl)-1,3-thiazole Chemical compound C1=CC([N+](=O)[O-])=CC=C1C1=CSC(CCl)=N1 LEBRGKZHLICZCZ-UHFFFAOYSA-N 0.000 description 2
- 206010003549 Asthenia Diseases 0.000 description 2
- 229960002327 Chloral Hydrate Drugs 0.000 description 2
- RNFNDJAIBTYOQL-UHFFFAOYSA-N Chloral hydrate Chemical compound OC(O)C(Cl)(Cl)Cl RNFNDJAIBTYOQL-UHFFFAOYSA-N 0.000 description 2
- 206010061428 Decreased appetite Diseases 0.000 description 2
- 238000002965 ELISA Methods 0.000 description 2
- 206010027327 Menstrual disease Diseases 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 210000004291 Uterus Anatomy 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 230000003213 activating Effects 0.000 description 2
- 230000000259 anti-tumor Effects 0.000 description 2
- 235000019789 appetite Nutrition 0.000 description 2
- 230000036528 appetite Effects 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 201000010309 chronic salpingitis Diseases 0.000 description 2
- 235000001671 coumarin Nutrition 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 239000003651 drinking water Substances 0.000 description 2
- 235000020188 drinking water Nutrition 0.000 description 2
- 235000017173 flavonoids Nutrition 0.000 description 2
- 241000411851 herbal medicine Species 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 235000009408 lignans Nutrition 0.000 description 2
- 229930013686 lignans Natural products 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 210000004914 menses Anatomy 0.000 description 2
- 230000005906 menstruation Effects 0.000 description 2
- 230000001264 neutralization Effects 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 244000052769 pathogens Species 0.000 description 2
- 150000007965 phenolic acids Chemical class 0.000 description 2
- 235000009048 phenolic acids Nutrition 0.000 description 2
- 230000025627 positive regulation of urine volume Effects 0.000 description 2
- 150000003431 steroids Chemical class 0.000 description 2
- 150000003432 sterols Chemical class 0.000 description 2
- 235000003702 sterols Nutrition 0.000 description 2
- 150000003505 terpenes Chemical class 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- 230000001225 therapeutic Effects 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 239000011573 trace mineral Substances 0.000 description 2
- 235000013619 trace mineral Nutrition 0.000 description 2
- 150000003648 triterpenes Chemical class 0.000 description 2
- UZPQVEVQJJKELH-HDOBETQRSA-N (2R,6Z)-6-[[(3Z,5S)-2,5-dihydroxy-3-[(E)-1-hydroxy-3-(4-hydroxyphenyl)prop-2-enylidene]-4,6-dioxo-5-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]cyclohexen-1-yl]methylidene]-2,5-dihydroxy-4-[(E)-3-(4-hydroxyphenyl)prop-2-enoyl]-2-[(2R,3R, Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1[C@](C\1=O)(O)C(=O)C(C(=O)\C=C\C=2C=CC(O)=CC=2)=C(O)C/1=C/C(C([C@@](O)([C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)C\1=O)=O)=C(O)/C/1=C(/O)\C=C\C1=CC=C(O)C=C1 UZPQVEVQJJKELH-HDOBETQRSA-N 0.000 description 1
- 210000001015 Abdomen Anatomy 0.000 description 1
- 210000000683 Abdominal Cavity Anatomy 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010000269 Abscess Diseases 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 206010002383 Angina pectoris Diseases 0.000 description 1
- RZVHIXYEVGDQDX-UHFFFAOYSA-N Anthraquinone Chemical compound C1=CC=C2C(=O)C3=CC=CC=C3C(=O)C2=C1 RZVHIXYEVGDQDX-UHFFFAOYSA-N 0.000 description 1
- 210000000702 Aorta, Abdominal Anatomy 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 208000006673 Asthma Diseases 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- WLYGSPLCNKYESI-YULFXFNBSA-N Carthamin Natural products O=C(/C=C/c1ccc(O)cc1)C=1C(=O)/C(=C\C=2C(=O)C(C(=O)/C=C/c3ccc(O)cc3)=C(O)[C@](O)([C@@H]3[C@@H](O)[C@H](O)[C@H](O)[C@H](CO)O3)C=2O)/C(=O)[C@](O)([C@H]2[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O2)C=1O WLYGSPLCNKYESI-YULFXFNBSA-N 0.000 description 1
- 210000003169 Central Nervous System Anatomy 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 206010012601 Diabetes mellitus Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 241000668709 Dipterocarpus costatus Species 0.000 description 1
- 206010013781 Dry mouth Diseases 0.000 description 1
- 210000003278 Egg Shell Anatomy 0.000 description 1
- 229940095399 Enema Drugs 0.000 description 1
- 241000792859 Enema Species 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 206010019233 Headache Diseases 0.000 description 1
- 208000008454 Hyperhidrosis Diseases 0.000 description 1
- 208000004044 Hypesthesia Diseases 0.000 description 1
- 206010020937 Hypoaesthesia Diseases 0.000 description 1
- 206010022114 Injury Diseases 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 206010024264 Lethargy Diseases 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- 208000004396 Mastitis Diseases 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 210000002464 Muscle, Smooth, Vascular Anatomy 0.000 description 1
- 210000003205 Muscles Anatomy 0.000 description 1
- 241000238367 Mya arenaria Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 229940069426 Nux Vomica extract Drugs 0.000 description 1
- 206010061876 Obstruction Diseases 0.000 description 1
- 206010030302 Oliguria Diseases 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 206010033799 Paralysis Diseases 0.000 description 1
- 210000003516 Pericardium Anatomy 0.000 description 1
- 206010036067 Polydipsia Diseases 0.000 description 1
- 206010036596 Premature ejaculation Diseases 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 241000206469 Pulsatilla Species 0.000 description 1
- 210000004915 Pus Anatomy 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 206010072736 Rheumatic disease Diseases 0.000 description 1
- 206010041497 Spermatorrhoea Diseases 0.000 description 1
- 208000010110 Spontaneous Platelet Aggregation Diseases 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- 208000004371 Toothache Diseases 0.000 description 1
- 210000003932 Urinary Bladder Anatomy 0.000 description 1
- 210000002700 Urine Anatomy 0.000 description 1
- 206010052769 Vertigos Diseases 0.000 description 1
- 206010047513 Vision blurred Diseases 0.000 description 1
- 229940088594 Vitamin Drugs 0.000 description 1
- 208000005946 Xerostomia Diseases 0.000 description 1
- 230000003187 abdominal Effects 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 150000001345 alkine derivatives Chemical class 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- LSQZJLSUYDQPKJ-NJBDSQKTSA-N amoxicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=C(O)C=C1 LSQZJLSUYDQPKJ-NJBDSQKTSA-N 0.000 description 1
- 229960003022 amoxicillin Drugs 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 238000000540 analysis of variance Methods 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000000844 anti-bacterial Effects 0.000 description 1
- 230000003064 anti-oxidating Effects 0.000 description 1
- 210000000436 anus Anatomy 0.000 description 1
- 230000001580 bacterial Effects 0.000 description 1
- 230000000975 bioactive Effects 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 210000000748 cardiovascular system Anatomy 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 229930016212 chalcones Natural products 0.000 description 1
- 235000005513 chalcones Nutrition 0.000 description 1
- 150000001789 chalcones Chemical class 0.000 description 1
- 210000000038 chest Anatomy 0.000 description 1
- 201000009230 common cold Diseases 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 230000000875 corresponding Effects 0.000 description 1
- 229960000956 coumarin Drugs 0.000 description 1
- 150000004775 coumarins Chemical class 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- 150000002009 diols Chemical class 0.000 description 1
- 150000004141 diterpene derivatives Chemical class 0.000 description 1
- 229930004069 diterpenes Natural products 0.000 description 1
- 238000001647 drug administration Methods 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 235000014103 egg white Nutrition 0.000 description 1
- 210000000969 egg white Anatomy 0.000 description 1
- 239000007920 enema Substances 0.000 description 1
- 230000001076 estrogenic Effects 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 235000021050 feed intake Nutrition 0.000 description 1
- 230000004634 feeding behavior Effects 0.000 description 1
- 235000021285 flavonoid Nutrition 0.000 description 1
- 235000019525 fullness Nutrition 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 230000000968 intestinal Effects 0.000 description 1
- 239000007928 intraperitoneal injection Substances 0.000 description 1
- XEEYBQQBJWHFJM-UHFFFAOYSA-N iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 1
- 229930012948 isoflavones Natural products 0.000 description 1
- 235000008696 isoflavones Nutrition 0.000 description 1
- 201000003453 lung abscess Diseases 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- PWHULOQIROXLJO-UHFFFAOYSA-N manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 1
- 239000011572 manganese Substances 0.000 description 1
- 229910052748 manganese Inorganic materials 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000003340 mental Effects 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000006011 modification reaction Methods 0.000 description 1
- 201000009240 nasopharyngitis Diseases 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000000414 obstructive Effects 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Polymers 0.000 description 1
- 238000003305 oral gavage Methods 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 230000001151 other effect Effects 0.000 description 1
- 150000002995 phenylpropanoid derivatives Chemical class 0.000 description 1
- 229930015704 phenylpropanoids Natural products 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000000770 pro-inflamatory Effects 0.000 description 1
- 235000019633 pungent taste Nutrition 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000000171 quenching Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000001850 reproductive Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 230000002269 spontaneous Effects 0.000 description 1
- 229930002600 steroidal saponins Natural products 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 210000000456 talus bone Anatomy 0.000 description 1
- 235000007586 terpenes Nutrition 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 231100000889 vertigo Toxicity 0.000 description 1
- 239000000273 veterinary drug Substances 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 229930003231 vitamins Natural products 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 239000008215 water for injection Substances 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/288—Taraxacum (dandelion)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/286—Carthamus (distaff thistle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/533—Leonurus (motherwort)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/56—Loganiaceae (Logania family), e.g. trumpetflower or pinkroot
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/89—Cyperaceae (Sedge family)
- A61K36/8905—Cyperus (flatsedge)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8969—Polygonatum (Solomon's seal)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/53—Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization
Abstract
The invention provides a traditional Chinese medicine compound preparation for treating salpingitis of laying hens and application thereof, and relates to the technical field of veterinary medicines. The traditional Chinese medicine compound preparation comprises the following traditional Chinese medicine components in parts by weight: 10-20 parts of dandelion, 5-15 parts of nux vomica, 10-20 parts of gypsum, 5-15 parts of safflower, 5-15 parts of motherwort, 5-15 parts of hedysarum polybotrys, 5-15 parts of flastem milkvetch seed, 5-15 parts of rhizoma polygonati and 5-15 parts of rhizoma cyperi. The traditional Chinese medicine components adopted by the invention are reasonable in compatibility, and the traditional Chinese medicine composition has the effects of clearing away heat and toxic materials, promoting blood circulation to remove blood stasis, expelling toxin and the like by combining the traditional Chinese medicine components. The traditional Chinese medicine compound preparation has a definite curative effect on preventing and treating salpingitis of the laying hens, and can obviously improve the health condition of the laying hens, improve the egg yield, reduce the defective egg rate, improve the egg yield, improve the production performance of the laying hens and increase the production benefit. The invention is prepared from natural traditional Chinese medicines, has strong pertinence, obvious curative effect, no drug resistance, drug residue and no toxic and harmful substances, and is more beneficial to human health.
Description
Technical Field
The invention relates to the technical field of veterinary drugs, and in particular relates to a traditional Chinese medicine compound preparation for treating salpingitis of laying hens and application thereof.
Background
With the rapid development of Chinese laying hen intensive breeding industry, diseases caused by bacteria or viruses are increased day by day, laying hen salpingitis caused by bacteria such as escherichia coli is a common disease of chickens, particularly laying hens, and is common in the laying period and the egg laying peak period. Laying hens infected with salpingitis are mainly characterized by pain, rigidity, drooping of two wings, loose feathers, leaning to the ground or lethargy of some abdomens, the produced eggs often have bloodstains on the eggshells, pus-like secretion is often discharged in the fallopian tubes, the feathers around and below the anus are polluted, the egg laying is difficult, the egg laying rate is obviously reduced, and the laying hens are easy to lay soft-shell eggs, thin-shell eggs, malformed eggs, preserved eggs, small-sized eggs and white preserved eggs.
In order to prevent and treat diseases such as salpingitis of laying hens and the like, farmers often add chemosynthetic drugs such as antibiotics and the like into feed or drinking water. The antibiotics are widely used in the breeding of the laying hens, and the production performance, the laying rate and the feed-egg ratio of the laying hens are improved to a certain extent. However, the wide application of antibiotics easily causes the strains to generate drug resistance, which not only affects the quality of eggs, but also remains in eggs and is harmful to human health. Therefore, a green and pollution-free preparation is urgently needed to be found and applied to the production of the laying hens, and the aims of preventing and treating reproductive diseases of the laying hens, improving the production performance, improving the egg quality and the like are fulfilled.
Chinese herbal medicines are concerned with due to the unique advantages of naturalness, multifunctionality, no toxic or side effect, no drug resistance and the like. The Chinese herbal medicine can treat diseases such as salpingitis of the laying hens, can provide a large amount of nutrient substances such as amino acid, vitamin, trace elements and the like for animals, can improve the utilization rate of feed and promote the growth of the laying hens, is rich in natural bioactive substances such as polysaccharide, organic acid, flavonoid, alkaloid and the like, can enhance the immunity of organisms, prevent and treat the diseases and keep the health, and therefore plays an important role in the breeding industry.
Veterinary common diarrhea-stopping granule, Chinese pulsatilla root oral liquid, white dragon granule and the like, and researches find that the preparation has poor effect and is easy to repeat when being used for treating salpingitis of laying hens; the Chinese medicinal powder for treating the salpingitis of the laying hens, which is prepared from the egg activating powder and the egg increasing powder, has the advantages of low cure rate, slow effect, low cost performance and the like in clinic, so that the development of the Chinese medicinal preparation for treating the salpingitis of the laying hens, which has a definite curative effect, is green and economic, has no resistance and toxic or side effect, is urgently needed.
Disclosure of Invention
Technical problem to be solved
Aiming at the defects of the prior art, the invention provides a Chinese herbal compound preparation for treating laying hen salpingitis, which has the advantages of definite curative effect, no resistance, no toxic or side effect and no pollution, and an application thereof.
(II) technical scheme
In order to achieve the purpose, the invention is realized by the following technical scheme:
on one hand, the invention provides a traditional Chinese medicine compound preparation for treating salpingitis of laying hens, which comprises the following traditional Chinese medicine components in parts by weight: 10-20 parts of dandelion, 5-15 parts of nux vomica, 10-20 parts of gypsum, 5-15 parts of safflower, 5-15 parts of motherwort, 5-15 parts of hedysarum polybotrys, 5-15 parts of flastem milkvetch seed, 5-15 parts of rhizoma polygonati and 5-15 parts of rhizoma cyperi.
Further, as a further optimization of the traditional Chinese medicine compound preparation for treating salpingitis of the laying hens, the traditional Chinese medicine compound preparation comprises the following traditional Chinese medicine components in parts by weight: 14-18 parts of dandelion, 8-12 parts of nux vomica, 13-18 parts of gypsum, 8-12 parts of safflower, 8-12 parts of motherwort, 8-12 parts of hedysarum polybotrys, 8-12 parts of flastem milkvetch seed, 8-12 parts of rhizoma polygonati and 8-12 parts of rhizoma cyperi.
Further, as a further optimization of the traditional Chinese medicine compound preparation for treating salpingitis of the laying hens, the traditional Chinese medicine compound preparation comprises the following traditional Chinese medicine components in parts by weight: 15 parts of dandelion, 10 parts of nux vomica, 15 parts of gypsum, 10 parts of safflower, 10 parts of motherwort, 10 parts of radix hedysari, 10 parts of flastem milkvetch seed, 10 parts of rhizoma polygonati and 10 parts of rhizoma cyperi.
Further, as a further optimization of the traditional Chinese medicine compound preparation for treating salpingitis of the laying hens, the dosage form of the traditional Chinese medicine compound preparation is powder or granules.
On the other hand, the invention provides a preparation method of a traditional Chinese medicine compound preparation for treating salpingitis of laying hens, which comprises the following steps:
(1) weighing the following traditional Chinese medicine components in parts by weight: 10-20 parts of dandelion, 5-15 parts of nux vomica, 10-20 parts of gypsum, 5-15 parts of safflower, 5-15 parts of motherwort, 5-15 parts of hedysarum polybotrys, 5-15 parts of flastem milkvetch seed, 5-15 parts of rhizoma polygonati and 5-15 parts of rhizoma cyperi; cleaning the raw materials, drying and crushing, and uniformly mixing to obtain traditional Chinese medicine coarse powder;
(2) decocting the coarse powder of the traditional Chinese medicine obtained in the step (1) with water for three times, each time lasting for 3 hours, then combining the decoctions, standing for 24 hours, filtering, concentrating the filtrate to a relative density of 1.24-1.26, and cooling to room temperature for later use;
(3) adding 65% ethanol into the concentrated filtrate obtained in the step (2), wherein the amount of the ethanol is 2.5-3 times of the weight of the filtrate, standing overnight, filtering, recovering ethanol from the filtrate, and concentrating to relative density of 1.42-1.44 to obtain Chinese medicinal fluid extract;
(4) and (4) spray-drying the traditional Chinese medicine clear paste obtained in the step (3), preparing into granules, sterilizing and packaging to obtain the traditional Chinese medicine compound preparation.
The invention also provides application of the traditional Chinese medicine compound preparation for treating salpingitis of the laying hens, and the traditional Chinese medicine compound preparation is used for treating the salpingitis of the laying hens, and the specific dosage is as follows: (1) the dosage form of the Chinese medicinal compound preparation is powder, and 1500 jin of the material is mixed every 1000 g; (2) the Chinese medicine compound preparation is granules, and 150 liters of mixed water is used for every 100 g.
The traditional Chinese medicine compound preparation of the invention has the following pharmacological actions of the traditional Chinese medicine components:
dandelion: bitter and sweet in taste, cold in nature, entering liver and stomach meridians; has effects in clearing away heat and toxic materials, relieving swelling, dispersing pathogen accumulation, and inducing diuresis for treating stranguria; can be used for treating furuncle, swelling, acute mastitis, scrofula, conjunctival congestion, pharyngalgia, pulmonary abscess, intestinal abscess, jaundice due to damp-heat pathogen, stranguria with heat, and pain; the composition contains effective components such as flavonoids, coumarins, phenolic acids, terpenes, sterols, polysaccharides and the like, and clinical researches show that the composition has pharmacological effects of bacteriostasis, antioxidation, anti-inflammation, anti-tumor gastrointestinal protection and the like.
Nux vomica: bitter taste, warm nature, entering liver and spleen meridians; has the effects of dredging collaterals, relieving pain, resolving hard mass and relieving swelling; can be used for treating traumatic injury, rheumatism, numbness, paralysis, and sore throat; the nux vomica extract contains alkaloids, terpenoids, steroids and glycosides thereof, organic acids and other effective components, and researches show that the nux vomica has the pharmacological effects of resisting tumors, regulating immunity, resisting inflammation and easing pain, regulating small intestine movement and the like.
Gypsum: sweet and pungent in flavor and cold in nature, entering lung and stomach meridians; has effects in expelling pathogenic factors from the exterior, expelling pathogenic factors from the muscles, clearing away heat, purging pathogenic water, relieving restlessness, and quenching thirst; can be used for treating common cold, fever, polydipsia, lung heat, cough, asthma, excessive stomach fire, headache, and toothache; gypsum Fibrosum contains various microelements such as calcium, ferrum, zinc, manganese, copper, etc., and has effects of enhancing organism immunity and resisting virus.
Safflower: pungent taste and warm nature, entering heart and liver meridians; has the effects of promoting blood circulation, dredging channels, removing blood stasis and relieving pain; can be used for treating amenorrhea, dysmenorrhea, lochiorrhea, thoracic obstruction, cardialgia, abdominal pain due to blood stasis, and pyocutaneous disease with swelling and pain; it comprises chemical components such as flavonoids, steroids, phenolic acids, diols, lignans, chalcones, alkynes and volatile oil, wherein carthamin is used as a main active component.
Motherwort: bitter and pungent in flavor, slightly cold in nature, entering liver, pericardium and bladder meridians; has effects in promoting blood circulation, regulating menstruation, promoting urination, relieving swelling, and clearing away heat and toxic materials; can be used for treating menoxenia, dysmenorrhea, amenorrhea, lochiorrhea, edema, oliguria, pyocutaneous disease, and toxic swelling; it contains chemical components such as alkaloid, diterpene, flavone, phenylethanoid glycoside, phenylpropanoid, coumarin, triterpene, organic acid, volatile oil, etc.; the study shows that the motherwort can obviously improve the production performance of the laying hens in the initial stage and enhance the immunity of the organism.
Radix hedysari: sweet in taste, slightly cold in nature, entering lung and spleen meridians; has effects in invigorating qi, invigorating yang, consolidating superficial resistance, arresting sweating, inducing diuresis, relieving swelling, promoting fluid production, nourishing blood, removing stagnation, relieving arthralgia, removing toxic materials, expelling pus, healing sore, and promoting granulation; can be used for treating deficiency of qi, asthenia, anorexia, loose stool, metrorrhagia, sallow complexion due to blood deficiency, and edema due to qi deficiency; modern pharmacological research shows that the astragalus polysaccharide has the effects of strengthening heart, promoting urination, reducing blood pressure, protecting liver, resisting inflammation, improving immunity and the like, and the main component of the astragalus is the astragalus polysaccharide, so that nonspecific and specific immunity can be obviously improved.
Flatstem milkvetch seed: sweet in flavor and warm in nature, and enters liver and kidney meridians; has effects of warming and invigorating liver and kidney, arresting spontaneous emission, arresting polyuria, and improving eyesight; can be used for treating lumbago due to kidney deficiency, spermatorrhea, premature ejaculation, leukorrhagia due to turbid urine, vertigo, and blurred vision; it mainly contains triterpene glycoside, flavone and many kinds of glycoside, isoflavone glycoside, amino acid and many kinds of fatty acid compounds and a large amount of trace elements; modern pharmacological research shows that the traditional Chinese medicine composition has the effects of contracting uterus and reducing urination, reducing blood pressure, resisting inflammation, protecting liver, resisting oxidation, improving blood rheological property, inhibiting platelet aggregation, regulating blood fat and the like.
Rhizoma polygonati: sweet in taste and neutral in nature, and has the effects of tonifying qi and yin, invigorating spleen, moistening lung and tonifying kidney, and the spleen, lung and kidney meridians are entered; can be used for treating deficiency of spleen-stomach qi, asthenia, essence and blood deficiency, xerostomia, anorexia, internal heat, and diabetes; rhizoma polygonati contains various chemical components such as polysaccharide, oligosaccharide, flavone, steroidal saponins, alkaloid, lignan, amino acid, inorganic elements, volatile oil and the like, and modern pharmacological research shows that the rhizoma polygonati has the effects of resisting oxidation, reducing blood sugar, regulating immunity, resisting bacteria, resisting inflammation and the like.
Rhizoma cyperi: pungent, slightly bitter, slightly sweet, neutral in nature, entering liver, spleen and triple energizer meridians; has effects in dispersing stagnated liver qi, relieving qi stagnation, regulating qi-flowing, relieving epigastric distention, regulating menstruation, and relieving pain; it is clinically used for treating liver qi stagnation, distending pain in chest and hypochondrium, qi stagnation in spleen and stomach, abdominal distention and fullness, distention and pain, menoxenia, amenorrhea and dysmenorrhea; the rhizoma cyperi contains volatile oil, flavone, alkaloid, triterpene, sterol, anthraquinone and other chemical components; modern pharmacological research shows that the rhizoma cyperi can act on a central nervous system, a cardiovascular system, a cerebrovascular system and a digestive system, can relax uterine smooth muscle, and has estrogen-like effects, depression resistance, blood sugar and blood fat reduction, anti-inflammatory, antibacterial, anti-tumor and other effects.
(III) advantageous effects
The invention provides a traditional Chinese medicine compound preparation for treating salpingitis of laying hens and application thereof. The Chinese medicinal compound preparation is prepared by reasonably mixing nine Chinese medicinal herbs such as dandelion, nux vomica, gypsum, safflower and the like according to the traditional Chinese medicine syndrome differentiation treatment principle, fully exerts the functions of the medicaments, has the effects of coordinating the medicaments and increasing the medicament effect, and has the effects of clearing heat and removing toxicity, promoting blood circulation to remove blood stasis, expelling toxin and the like. Animal experiments and clinical experiments show that the traditional Chinese medicine compound preparation has a definite curative effect on preventing and treating salpingitis of the laying hens, and can obviously improve the health condition of the laying hens, improve the egg yield, reduce the defective egg rate, improve the egg yield, improve the production performance of the laying hens and increase the production benefit. The invention is prepared from natural traditional Chinese medicines, has strong pertinence, obvious curative effect, no drug resistance, drug residue and no toxic and harmful substances, and is more beneficial to human health.
Detailed Description
In order to make the objects, technical solutions and advantages of the embodiments of the present invention clearer, the technical solutions in the embodiments of the present invention will be clearly and completely described below with reference to the embodiments of the present invention, and it is obvious that the described embodiments are some embodiments of the present invention, but not all embodiments. All other embodiments, which can be derived by a person skilled in the art from the embodiments given herein without making any creative effort, shall fall within the protection scope of the present invention.
Example 1
A traditional Chinese medicine compound preparation for treating salpingitis of laying hens is prepared according to the following steps:
(1) weighing the following traditional Chinese medicine components in parts by weight: 10 parts of dandelion, 5 parts of nux vomica, 10 parts of gypsum, 5 parts of safflower, 5 parts of motherwort, 5 parts of radix hedysari, 5 parts of flatstem milkvetch seed, 5 parts of rhizoma polygonati and 5 parts of rhizoma cyperi; cleaning the raw materials, drying and crushing, and uniformly mixing to obtain traditional Chinese medicine coarse powder;
(2) decocting the coarse powder of the traditional Chinese medicine obtained in the step (1) with water for three times, each time lasting for 3 hours, then combining the decoctions, standing for 24 hours, filtering, concentrating the filtrate to a relative density of 1.24-1.26, and cooling to room temperature for later use;
(3) adding 65% ethanol into the concentrated filtrate obtained in the step (2), wherein the amount of the ethanol is 2.5-3 times of the weight of the filtrate, standing overnight, filtering, recovering ethanol from the filtrate, and concentrating to relative density of 1.42-1.44 to obtain Chinese medicinal fluid extract;
(4) and (4) spray-drying the traditional Chinese medicine clear paste obtained in the step (3), preparing into granules, sterilizing and packaging to obtain the traditional Chinese medicine compound preparation.
The prepared traditional Chinese medicine compound preparation is used for treating salpingitis of laying hens, and the specific dosage is as follows: 150 liters per 100g of mixed water.
Example 2
This embodiment is different from embodiment 1 in that
Raw materials (by weight portion): 20 parts of dandelion, 15 parts of nux vomica, 20 parts of gypsum, 15 parts of safflower, 15 parts of motherwort, 15 parts of radix hedysari, 15 parts of flastem milkvetch seed, 15 parts of rhizoma polygonati and 15 parts of rhizoma cyperi.
Example 3
This embodiment is different from embodiment 1 in that
Raw materials (by weight portion): 18 parts of dandelion, 12 parts of nux vomica, 18 parts of gypsum, 12 parts of safflower, 12 parts of motherwort, 12 parts of radix hedysari, 12 parts of flastem milkvetch seed, 12 parts of rhizoma polygonati and 12 parts of rhizoma cyperi.
Example 4
This embodiment is different from embodiment 1 in that
Raw materials (by weight portion): 14 parts of dandelion, 8 parts of nux vomica, 13 parts of gypsum, 8 parts of safflower, 8 parts of motherwort, 8 parts of radix hedysari, 8 parts of flastem milkvetch seed, 8 parts of rhizoma polygonati and 8 parts of rhizoma cyperi.
Example 5
This embodiment is different from embodiment 1 in that
Raw materials (by weight portion): 15 parts of dandelion, 10 parts of nux vomica, 15 parts of gypsum, 10 parts of safflower, 10 parts of motherwort, 10 parts of radix hedysari, 10 parts of flastem milkvetch seed, 10 parts of rhizoma polygonati and 10 parts of rhizoma cyperi.
Example 6
This embodiment is different from embodiment 1 in that
Raw materials (by weight portion): 12 parts of dandelion, 6 parts of nux vomica, 12 parts of gypsum, 6 parts of safflower, 14 parts of motherwort, 6 parts of radix hedysari, 6 parts of flastem milkvetch seed, 14 parts of rhizoma polygonati and 8 parts of rhizoma cyperi.
Example 7
(1) Weighing the following traditional Chinese medicine components in parts by weight: 15 parts of dandelion, 10 parts of nux vomica, 15 parts of gypsum, 10 parts of safflower, 10 parts of motherwort, 10 parts of radix hedysari, 10 parts of flastem milkvetch seed, 10 parts of rhizoma polygonati and 10 parts of rhizoma cyperi; cleaning the raw materials, drying and crushing, and uniformly mixing to obtain traditional Chinese medicine coarse powder;
(2) and (2) crushing the Chinese medicinal coarse powder obtained in the step (1) again to obtain Chinese medicinal superfine powder with the particle size of 300-.
The prepared traditional Chinese medicine compound preparation is used for treating salpingitis of laying hens, and the specific dosage is as follows: 1500 jin per 1000g of the material.
The invention adopts the theory of traditional Chinese medicine, selects medicinal materials and makes the prescription of the medicinal materials, and because the experimental data is more, the prescription is adjusted and tested for many times, only a plurality of groups of prescriptions with higher curative effect are listed and compared with the prescription of the invention.
Formula 1: 10 parts of nux vomica, 15 parts of gypsum, 10 parts of safflower, 10 parts of motherwort, 10 parts of radix hedysari, 10 parts of flatstem milkvetch seed and 10 parts of rhizoma polygonati.
And (2) formula: 15 parts of dandelion, 10 parts of safflower, 10 parts of motherwort, 10 parts of radix hedysari, 10 parts of flatstem milkvetch seed, 10 parts of rhizoma polygonati and 10 parts of rhizoma cyperi.
And (3) formula: 15 parts of dandelion, 10 parts of nux vomica, 15 parts of gypsum, 10 parts of motherwort, 10 parts of radix hedysari, 10 parts of flatstem milkvetch seed and 10 parts of rhizoma cyperi.
And (4) formula: 15 parts of dandelion, 10 parts of nux vomica, 15 parts of gypsum, 10 parts of safflower, 10 parts of rhizoma polygonati and 10 parts of rhizoma cyperi.
The formula of the invention is as follows: 15 parts of dandelion, 10 parts of nux vomica, 15 parts of gypsum, 10 parts of safflower, 10 parts of motherwort, 10 parts of radix hedysari, 10 parts of flastem milkvetch seed, 10 parts of rhizoma polygonati and 10 parts of rhizoma cyperi.
The Chinese medicinal preparations are respectively prepared according to the formulas, the preparation steps are prepared according to the steps of example 1, and the Chinese medicinal granules under each formula are respectively obtained.
The test method comprises the following steps:
selecting SPF SD rats, female rats, 80 rats and body mass (185 +/-15 g); the method of the reference literature (Zhanghouxiang, Qiuhao, Chengjing, etc. an experimental study on the treatment of chronic salpingitis by an anti-inflammatory and vein-relaxing enema method [ J ] Chinese traditional medicine, 2013, 31 (6): 1378-1381.) adopts a mixed strain inoculation method to prepare a rat model of chronic salpingitis. The 10% chloral hydrate is used for performing intraperitoneal injection anesthesia according to the dose of 3mL/kg, the abdominal cavity is opened, the rats in other groups except the blank group are respectively injected with 20 mu L of mixed bacterial liquid to the two oviducts at the position of the uterus close to the oviducts, 20 mu L of physiological saline is injected into the blank group, and then the wound is sutured.
Rats are divided into a blank group, a model group, a positive control group, a formula 1-4 group and a traditional Chinese medicine granule group according to weight layering at random, and each group comprises 10 rats. The model is built for 7 groups except the blank group, the administration by gastric gavage is started 11 days after the model is built, 2mL of water for injection by gastric gavage is taken for rats in the blank group and the model group every day, 0.4g/kg of Jingangteng capsule is taken for the positive control group by gastric gavage, the traditional Chinese medicine particles obtained by the formulas 1 to 4 and the traditional Chinese medicine particles of the invention are respectively taken for oral gavage for the formulas 1 to 4 and the traditional Chinese medicine particles of the invention, the dose is 0.5g/kg, and the continuous administration is carried out for.
After 25 days of administration, rats are anesthetized with 10% chloral hydrate, blood is taken from abdominal aorta, serum is obtained by centrifugation, and indicators of proinflammatory factors IL-2, IL-6 and TNF-alpha related to salpingitis of the serum of the rats are detected by an enzyme-linked immunosorbent assay (ELISA). The results are shown in Table 1.
The experimental data are statistically analyzed by SPSS19.0 statistical software, and the results are expressed asxS, and comparisons between groups were tested using analysis of variance.
TABLE 1 detection results of inflammation-related indices in rat serum (' sx±s）
| Group of | n | IL-2（pg/mL） | IL-6（pg/mL） | TNF-α（pg/mL） |
| Blank group | 10 | 1.56±0.03 | 123.65±11.36 | 192.36±5.12 |
| Model set | 10 | 1.87±0.07a | 181.97±15.44a | 298.10±4.99 a |
| Positive control group | 10 | 1.73±0.11ab | 157.22±9.71 ab | 255.42±9.70 ab |
| Formulation 1 group | 10 | 1.69±0.14ab | 150.78±13.74 ab | 248.09±9.33 ab |
| Formulation 2 group | 10 | 1.71±0.02ab | 156.03±11.00 ab | 253.03±4.61 ab |
| Formulation 3 group | 10 | 1.70±0.05ab | 154.69±14.52 ab | 250.85±7.16 ab |
| Formulation 4 group | 10 | 1.74±0.13ab | 162.40±8.91 ab | 258.31±5.49 ab |
| The invention relates to a traditional Chinese medicine granule group | 10 | 1.61±0.20bc | 139.16±12.03 abc | 238.45±7.36 abc |
Note: a <0.05 compared to blank; b <0.05 compared to model group; c P <0.05 compared to positive control group.
Compared with the blank group, the indexes of the serum IL-6 and TNF-alpha of the model group, the positive control group, the formula 1-4 groups and the traditional Chinese medicine granule group are obviously improved and have significant difference (P is less than 0.05); compared with the model group, the serum IL-6 and TNF-alpha indexes of the positive control group, the formula 1-4 groups and the traditional Chinese medicine granule group are obviously reduced and have significant difference (P is less than 0.05); the serum IL-6 and TNF-alpha indexes of the traditional Chinese medicine granule group are obviously reduced compared with those of a positive control group and a formula 1-4 group, and the obvious difference (P < 0.05) exists, and the results are detailed in a table 1.
Compared with the blank group, the serum IL-2 indexes of the model group, the positive control group and the formula 1-4 groups are obviously increased and have significant difference (P is less than 0.05); compared with the model group, the serum IL-2 indexes of the positive control group, the formula 1-4 groups and the traditional Chinese medicine granule group are obviously reduced and have significant difference (P is less than 0.05); the serum IL-2 index of the traditional Chinese medicine granule group is obviously reduced and has obvious difference (P is less than 0.05) compared with the positive control group and the formula 1-4 groups, and the result of the serum IL-2 index of the traditional Chinese medicine granule group has no obvious difference (P is more than 0.05) compared with the blank group is detailed in table 1.
The test results show that the traditional Chinese medicine granules can obviously relieve salpingitis of a rat salpingitis model caused by mixed bacteria, can more obviously reduce the contents of IL-2, IL-6 and TNF-alpha in serum compared with the formula 1-4 groups, and have more effective anti-inflammatory action. The Chinese medicinal compound preparation is prepared from nine Chinese medicinal herbs such as dandelion, nux vomica, gypsum, safflower and the like by reasonable compatibility according to the traditional Chinese medicine syndrome differentiation treatment principle, the effects of all the medicaments are fully exerted, all the medicaments coordinate to enhance the medicinal effect, and all the ingredients in the formula are absent.
To further illustrate the therapeutic effect of the present invention's dispersed granules on salpingitis of laying hens, animal experiments are provided below as an illustration. The following Chinese medicinal granules are prepared according to example 5, and the powder is prepared according to example 7.
1 materials and methods
1.1 test drugs
The traditional Chinese medicine granule, the traditional Chinese medicine powder, the amoxicillin soluble powder with the concentration of 10 percent and the egg activating powder
1.2 test animals
2000 feathers of 360-day-old laying hens are randomly divided into five groups, namely a blank group, a test group 1, a test group 2, a drug control group 1 and a drug control group 2. Each group has 500 feathers. Before the test is started, the chickens have the characteristics of salpingitis symptoms such as turbid egg white, soft eggs, blood spot eggs, preserved eggs, low laying rate and the like, and the defective egg rate is 3-4% every day.
1.3 test methods
1.3.1 the drugs are dosed (mixed or mixed with water) in the feed according to the dosage shown in the table 2, the drugs are continuously dosed for 7 days, and the drugs are stopped after 7 days.
TABLE 2 test groups and drug administration dose
1.3.2 Each group experiment was carried out under the same feeding conditions. The 360 day old chickens began weighing and counting the eggs laid by the entire experimental group 7 days before the experiment, and the eggs laid by the entire experimental group were weighed and counted within half a month from the beginning of the experiment.
1.3.3 items of observation measurement: observing the change and health condition of chicken group every day, recording feed intake, egg yield, egg weight, and number of eggs (including soft egg, egg with blood spot, preserved egg, broken egg, etc.), and calculating feed-egg ratio and laying rate.
Treatment effect judgment standard: (1) the method has the following advantages: the disease chicken recovers the normal spirit and appetite, the disease chicken gradually recovers, the laying rate is increased, the number of inferior eggs is reduced, and the disease chicken recurs in the observation period; (2) and (3) curing: the spirit and the appetite of the sick chicken are recovered to be normal, the laying rate is increased to some extent, the number of inferior eggs is reduced, and the bad eggs do not relapse; (3) and (4) invalidation: after the medicine is taken, the symptoms of the sick chicken are not relieved, even aggravated or dead, the laying rate is continuously reduced, and the number of inferior eggs is increased.
2 results and analysis
2.1 clinical manifestations of egg-laying hens
After the treatment period is finished, the hens in the test groups 1 and 2 and the hens in the drug control groups 1 and 2 have better mental recovery, the drinking water and the eating are normal, the laying rate is increased, the number of the inferior eggs is obviously reduced, and the results in the table 3 show that the cure rate and the effective number of the test groups 1 and 2 are both higher than those of the drug control groups 1 and 2, and the ineffective number is far lower than those of the drug control groups 1 and 2.
TABLE 3 therapeutic Effect of the groups of layers
| Group of | Quantity (only) | Cure (only) | Effective (only) | Invalid (only) | Cure rate (%) |
| Blank group | 500 | － | － | － | － |
| Test group 1 | 500 | 481 | 490 | 10 | 96.2 |
| Test group 2 | 500 | 483 | 492 | 8 | 96.6 |
| Control drug group 1 | 500 | 445 | 476 | 23 | 89.0 |
| Control drug group 2 | 500 | 461 | 482 | 18 | 92.2 |
2.2 laying hen Productivity
As can be seen from the results in table 4, comparing the laying performance of the laying hens 7 days before and after the treatment period, firstly, the egg laying rates of the test groups 1 and 2 and the control drug groups 1 and 2 are obviously increased, the egg laying rates are respectively increased by 3.0%, 5%, 1.8% and 2.2%, and the egg laying rate of the blank group is reduced; the egg weight of the blank group is reduced, the egg ratio is increased, the feed-egg ratio is increased, the egg weight of the test groups 1 and 2 and the egg weight of the drug control groups 1 and 2 are increased, the egg ratio is also reduced, and the feed-egg ratio is obviously reduced; compared with the drug control groups 1 and 2, the test groups 1 and 2 show more excellent production performance, and from the result, the laying rate of the test groups 1 and 2 is about 0.8-3.2% higher than that of the drug control groups 1 and 2, the egg laying rate of the test groups 1 and 2 is kept below 1%, and the feed-egg ratio is obviously reduced. The results are consistent with the clinical manifestations of the laying hens, which shows that the traditional Chinese medicine compound preparation disclosed by the invention has more advantages and more obvious curative effects on the treatment of salpingitis of the laying hens, and is expected to replace the traditional veterinary medicines and avoid the use of antibiotics. The dosage form of the traditional Chinese medicine compound preparation has no influence on the drug effect, and test results show that the powder and the granules both have excellent prevention and treatment effects on the salpingitis of the laying hens.
TABLE 4 egg-laying hen production Performance
Discussion of 3
The Chinese medicinal compound preparation is prepared by reasonably mixing nine Chinese medicinal herbs such as dandelion, nux vomica, gypsum, safflower and the like according to the traditional Chinese medicine syndrome differentiation treatment principle, fully exerts the functions of the medicaments, has the effects of coordinating the medicaments and increasing the medicament effect, and has the effects of clearing heat and removing toxicity, promoting blood circulation to remove blood stasis, expelling toxin and the like. The tests can prove that the traditional Chinese medicine compound preparation has a definite curative effect on preventing and treating salpingitis of the laying hens, and the laying rate can be obviously improved, the health condition of the laying hens is improved, the defective egg rate is reduced, the laying rate is improved, the production performance of the laying hens is improved, and the production benefit is increased. The invention is prepared from natural traditional Chinese medicines, has strong pertinence, obvious curative effect, no drug resistance, drug residue and no toxic and harmful substances, and is more beneficial to human health.
The above examples are only intended to illustrate the technical solution of the present invention, but not to limit it; although the present invention has been described in detail with reference to the foregoing embodiments, it will be understood by those of ordinary skill in the art that: the technical solutions described in the foregoing embodiments may still be modified, or some technical features may be equivalently replaced; and such modifications or substitutions do not depart from the spirit and scope of the corresponding technical solutions of the embodiments of the present invention.
Claims (6)
1. The traditional Chinese medicine compound preparation for treating salpingitis of the laying hens is characterized by comprising the following traditional Chinese medicine components in parts by weight: 10-20 parts of dandelion, 5-15 parts of nux vomica, 10-20 parts of gypsum, 5-15 parts of safflower, 5-15 parts of motherwort, 5-15 parts of hedysarum polybotrys, 5-15 parts of flastem milkvetch seed, 5-15 parts of rhizoma polygonati and 5-15 parts of rhizoma cyperi.
2. The compound traditional Chinese medicine preparation for treating salpingitis of laying hens according to claim 1, which is prepared from the following traditional Chinese medicine components in parts by weight: 14-18 parts of dandelion, 8-12 parts of nux vomica, 13-18 parts of gypsum, 8-12 parts of safflower, 8-12 parts of motherwort, 8-12 parts of hedysarum polybotrys, 8-12 parts of flastem milkvetch seed, 8-12 parts of rhizoma polygonati and 8-12 parts of rhizoma cyperi.
3. The compound traditional Chinese medicine preparation for treating salpingitis of laying hens according to claim 1, which is prepared from the following traditional Chinese medicine components in parts by weight: 15 parts of dandelion, 10 parts of nux vomica, 15 parts of gypsum, 10 parts of safflower, 10 parts of motherwort, 10 parts of radix hedysari, 10 parts of flastem milkvetch seed, 10 parts of rhizoma polygonati and 10 parts of rhizoma cyperi.
4. The compound traditional Chinese medicine preparation for treating salpingitis of laying hens according to claim 1, wherein the dosage form of the compound traditional Chinese medicine preparation is powder or granules.
5. The preparation method of the traditional Chinese medicine compound preparation for treating salpingitis of laying hens, which is disclosed by claim 1, is characterized by comprising the following steps of:
(1) weighing the following traditional Chinese medicine components in parts by weight: 10-20 parts of dandelion, 5-15 parts of nux vomica, 10-20 parts of gypsum, 5-15 parts of safflower, 5-15 parts of motherwort, 5-15 parts of hedysarum polybotrys, 5-15 parts of flastem milkvetch seed, 5-15 parts of rhizoma polygonati and 5-15 parts of rhizoma cyperi; cleaning the raw materials, drying and crushing, and uniformly mixing to obtain traditional Chinese medicine coarse powder;
(2) decocting the coarse powder of the traditional Chinese medicine obtained in the step (1) with water for three times, each time lasting for 3 hours, then combining the decoctions, standing for 24 hours, filtering, concentrating the filtrate to a relative density of 1.24-1.26, and cooling to room temperature for later use;
(3) adding 65% ethanol into the concentrated filtrate obtained in the step (2), wherein the amount of the ethanol is 2.5-3 times of the weight of the filtrate, standing overnight, filtering, recovering ethanol from the filtrate, and concentrating to relative density of 1.42-1.44 to obtain Chinese medicinal fluid extract;
(4) and (4) spray-drying the traditional Chinese medicine clear paste obtained in the step (3), preparing into granules, sterilizing and packaging to obtain the traditional Chinese medicine compound preparation.
6. The application of the traditional Chinese medicine compound preparation for treating salpingitis of laying hens, which is disclosed by claim 1, is characterized in that the traditional Chinese medicine compound preparation is a medicine for treating salpingitis of laying hens, and the specific dosage is as follows: (1) the dosage form of the Chinese medicinal compound preparation is powder, and 1500 jin of the material is mixed every 1000 g; (2) the Chinese medicine compound preparation is granules, and 150 liters of mixed water is used for every 100 g.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010800627.0A CN111789913B (en) | 2020-08-11 | 2020-08-11 | Traditional Chinese medicine compound preparation for treating salpingitis of laying hens and application |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010800627.0A CN111789913B (en) | 2020-08-11 | 2020-08-11 | Traditional Chinese medicine compound preparation for treating salpingitis of laying hens and application |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN111789913A true CN111789913A (en) | 2020-10-20 |
| CN111789913B CN111789913B (en) | 2022-02-01 |
Family
ID=72833964
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202010800627.0A Active CN111789913B (en) | 2020-08-11 | 2020-08-11 | Traditional Chinese medicine compound preparation for treating salpingitis of laying hens and application |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN111789913B (en) |
Citations (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101129938A (en) * | 2007-09-24 | 2008-02-27 | 北京艺信堂医药研究所 | Traditional Chinese medicine formulated product for treating salpingitis |
| CN101658245A (en) * | 2009-08-26 | 2010-03-03 | 王直军 | Chinese medicinal feed additive for preventing and treating hen salpingitis |
| CN101810829A (en) * | 2010-05-13 | 2010-08-25 | 西双版纳傣族自治州民族医药研究所 | Medicament for treating mastopathy |
| CN102038090A (en) * | 2010-09-02 | 2011-05-04 | 吴艳霞 | Feed additive prepared from traditional Chinese medicines and used for preventing and treating salpingitis of chickens |
| CN105998304A (en) * | 2016-07-01 | 2016-10-12 | 河南中医学院 | Traditional Chinese medicine anal suppository for treating accumulated damp heat sequelae of pelvic inflammatory disease |
| CN106963918A (en) * | 2017-04-06 | 2017-07-21 | 黄冈福鹤养殖有限公司 | A kind of Chinese medicine composition and decoction for being used to prevent laying hen diseases of fallopian tubes |
| CN108567875A (en) * | 2018-07-16 | 2018-09-25 | 李焱焱 | A kind of Chinese medicine composition and its Chinese medicine preparation for treating salpingitis of layer chicken |
| CN110464809A (en) * | 2019-08-09 | 2019-11-19 | 申亚农牧科技股份有限公司 | A kind of additive that treating salpingitis of layer chicken and compound additive and preparation method |
-
2020
- 2020-08-11 CN CN202010800627.0A patent/CN111789913B/en active Active
Patent Citations (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101129938A (en) * | 2007-09-24 | 2008-02-27 | 北京艺信堂医药研究所 | Traditional Chinese medicine formulated product for treating salpingitis |
| CN101658245A (en) * | 2009-08-26 | 2010-03-03 | 王直军 | Chinese medicinal feed additive for preventing and treating hen salpingitis |
| CN101810829A (en) * | 2010-05-13 | 2010-08-25 | 西双版纳傣族自治州民族医药研究所 | Medicament for treating mastopathy |
| CN102038090A (en) * | 2010-09-02 | 2011-05-04 | 吴艳霞 | Feed additive prepared from traditional Chinese medicines and used for preventing and treating salpingitis of chickens |
| CN105998304A (en) * | 2016-07-01 | 2016-10-12 | 河南中医学院 | Traditional Chinese medicine anal suppository for treating accumulated damp heat sequelae of pelvic inflammatory disease |
| CN106963918A (en) * | 2017-04-06 | 2017-07-21 | 黄冈福鹤养殖有限公司 | A kind of Chinese medicine composition and decoction for being used to prevent laying hen diseases of fallopian tubes |
| CN108567875A (en) * | 2018-07-16 | 2018-09-25 | 李焱焱 | A kind of Chinese medicine composition and its Chinese medicine preparation for treating salpingitis of layer chicken |
| CN110464809A (en) * | 2019-08-09 | 2019-11-19 | 申亚农牧科技股份有限公司 | A kind of additive that treating salpingitis of layer chicken and compound additive and preparation method |
Non-Patent Citations (4)
| Title |
|---|
| 尹定良，等: "中西医结合治疗樱桃谷种鸭输卵管炎", 《河南畜牧兽医》 * |
| 霍书英，等: ""益母散"对蛋鸡输卵管修复和产蛋性能的影响", 《中国家禽》 * |
| 韩连玉，等: "中西医结合治疗慢性输卵管炎阻塞性不孕症140例临床观察", 《河北中医》 * |
| 黄文华，等: "激蛋散加减治蛋鸡输卵管炎、肠炎", 《四川畜牧兽医》 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN111789913B (en) | 2022-02-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104799115A (en) | Chicken compound feed and preparation method thereof | |
| CN103386022A (en) | Chinese medicine composition for treating tuberculous pleurisy | |
| CN103494927B (en) | Traditional Chinese medicine composition for treating chicken respiratory disease and preparation method thereof | |
| CN103055065B (en) | Pure Chinese medicinal composition for treating enteritis of fish and preparation method of pure Chinese medicinal composition | |
| CN103301353B (en) | Pharmaceutical composition for treating atrophic vaginitis | |
| CN103285284B (en) | Medical composition for treating senile vaginitis | |
| CN105213941A (en) | A kind of Chinese medicine composition being used for the treatment of infantile diarrhea and preparation method thereof | |
| CN102552657B (en) | Chinese medicinal composition used for treating Newcastle disease of chicken | |
| CN111789913B (en) | Traditional Chinese medicine compound preparation for treating salpingitis of laying hens and application | |
| CN104983968B (en) | Antipyretic traditional Chinese medicine composition and preparation method thereof | |
| CN101708286B (en) | Chinese patent medicament for treating sjogren's syndrome and intractable oral ulcer, and preparation method thereof | |
| CN103055207B (en) | Pure Chinese medicinal composition for treating infectious hemorrhagic disease of grass carp and preparation method thereof | |
| CN104887950A (en) | Mastitis treatment traditional Chinese medicine compound | |
| CN104771585A (en) | Traditional Chinese medicine composition for treating acute nephritis and preparation method thereof | |
| CN103705857B (en) | For preventing the Chinese medicine composition of oral cavity radiomucitis | |
| CN102727669B (en) | Compound propolis composition used for treating swine erysipelas, and preparation method thereof | |
| CN113813344B (en) | Composition for treating joint pain and mastitis of lying-in women and application thereof | |
| CN106334155A (en) | Traditional Chinese medicine composition for treating arterial thyromegaly and preparation method thereof | |
| CN111760004B (en) | Traditional Chinese medicine granules for preventing and treating livestock and poultry influenza and application thereof | |
| CN106620266A (en) | Traditional Chinese medicine composition for treating mycoplasmal pneumonia of swine | |
| CN105434670A (en) | Traditional Chinese medicine preparation for treating costal chondritis and preparation method thereof | |
| CN101028352A (en) | Chinese-medicinal preparation for treating ischiodynia | |
| CN104758749A (en) | Traditional Chinese medicine composition for treating liver cancer | |
| CN104707124A (en) | Traditional Chinese medicine preparation for treating chronic endometritis | |
| CN104524149A (en) | Pharmaceutical composition for preventing and treating acute nephritis and application thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |